
- Mount Sinai Doctors
- Treats Children & Adults
- Video Visit Available
- Accepting New Patients
Manisha Balwani, MD, MS
Genetics and Genomics
About Me
Dr. Manisha Balwani is a Professor in the Department of Genetics and Genomic Sciences and Department of Medicine at the Icahn School of Medicine at Mount Sinai and Chief of the Division of Medical Genetics and Genomics. Her clinical interests include Lysosomal Storage Diseases and the Porphyrias. She is the Director of the Lysosomal Disease Program and a faculty member of the Icahn Genomics Institute.
Dr. Balwani completed her medical training at the University of Bombay, followed by a Master’s in Genetics at the University of Pittsburgh. She completed her training in Internal Medicine followed by a fellowship in Medical Genetics and Clinical Biochemical Genetics. She joined the faculty of the Department of Genetics at the Icahn School of Medicine in 2006.
Her initial research efforts were focused on the natural history and genotype-phenotype correlations of Gaucher disease. She served as Principal Investigator for therapeutic clinical trials for new therapies for Gaucher disease and Lysosomal Acid Lipase deficiency. Her recent research efforts have been focused on the acute and cutaneous porphyrias. She is an investigator for the NIH supported Rare Diseases Clinical Research Network’s Porphyrias Consortium.
Dr. Balwani was awarded the 2023 Mount Sinai Cullman Family Award for Excellence in Provider Communication. This award recognizes providers who rank in the top 5% nationally in provider communication in the Press Ganey patient experience surveys, with only 72 Mount Sinai providers of over 97,000 providers receiving this exceptional recognition in 2023.
As an experienced physician scientist, Dr. Balwani has been the PI of investigator-initiated and industry sponsored studies and clinical trials.
Language
English
Position
PROFESSOR | Genetics and Genomic Sciences, PROFESSOR | Medicine, General Internal Medicine
Hospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai Morningside
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
Clinical Focus
Video
Education
MD, Topiwala National Medical College
Master of Science, University of Pittsburgh - Graduate School of Public Health
Residency, Internal Medicine
Long Island Jewish Forest Hills
Fellowship, Medical Genetics
Mount Sinai Hospital
Fellowship, Medical Biochemical Genetics
Mount Sinai Hospital
Certifications
American Board of Medical Genetics & Genomics
Awards
2012
NIH K23 Mentored Patient-Oriented Career Development Award
2009
Genetic Disease Foundation “Clinical Excellence Award”
2006
NORD/Roscoe Brady Lysosomal Diseases Fellowship Award
Research
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
- 1199 SEIU
- AETNA - Commercial
- AETNA - Medicare
- Affinity Medicaid-Medicare-Essential Exchange
- Amidacare Medicaid
- CIGNA Healthcare
- Centivo
- Elderplan
- EmblemHealth - GHI-PPO
- EmblemHealth - HIP
- EmblemHealth - HIP-Medicaid
- EmblemHealth - HIP-Medicare
- Empire Blue Cross Blue Shield - Commercial/Exchange
- Empire Blue Cross Blue Shield - HealthPlus Medicaid
- Empire Blue Cross Blue Shield - Medicare
- Fidelis Health Care
- HealthFirst Medicaid
- HealthFirst Medicare
- Horizon NJ
- Magnacare-Health Care
- Medicare - NJ
- Medicare - NY
- Metroplus
- Multiplan PHCS
- NJ Medicaid
- NY Medicaid
- Oscar
- Oxford - Freedom and Liberty
- Partners Health Plan
- Senior Whole Health
- United Health Care - Commercial
- United Health Care - Empire Plan
- United Health Care - Oxford Care
- United Health Care - Top Tier
- VNSNY Choice Medicare
- VillageCareMax
- WellCare Health Plan
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- A Prospective, Blinded Study of Symptom Prevalence and Specificity of Porphyrin Precursors in Carriers of Acute Hepatic Porphyria. Mohsen Merati, Nanditha Jayakumar, Yuvraaj Kapoor, Hetanshi Naik, Manisha Balwani, Karl E. Anderson, Herbert L. Bonkovsky, Robert J. Desnick, Brendan McGuire, John Phillips, D. Montgomery Bissell, Bruce Wang. Liver International
- Self-Reported Liver Disease and the Burden of Erythropoietic Protoporphyria. Hetanshi Naik, Kristen Wheeden, Hilary H. Colwell, Susan D. Mathias, Chelsea Norregaard, Melanie Chin, William Savage, Manisha Balwani. JIMD Reports
- Case-based discussion of the acute hepatic porphyrias: Updates on pathogenesis, diagnosis and management. Manisha Balwani, Siobán Keel, Peter Meissner, Mark Sonderup, Penelope Stein, Makiko Yasuda. Liver International
Patient Experience Star Ratings and Comments
The Patient Experience Star Rating reflects our patients’ perception of how well their Mount Sinai provider communicated with them during an office visit. The Star Rating is based on patient responses to three questions on a patient experience survey, a standardized questionnaire sent to verified patients and distributed by a third party vendor, Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Balwani during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Board Service
- American Porphyria Expert Collaborative
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Disc Medicine, Inc.
- Sanofi Genzyme
- Alexion Pharmaceuticals
- Medison pharma
- CRISPR therapeutics
- Novartis Pharmaceutical Corporation
- Alnylam Pharma
- Recordati Rare Diseases
- Editas Medicine, Inc
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.